Any retatrutide obtained outside of a formal, ethics-approved clinical trial is classified as a research chemical and is not intended for human use under current UK regulations
They are not FDA-approved to diagnose, treat, cure, or prevent any disease
The World Anti-Doping Agency bans both compounds at all times: BPC-157 under S0 (Non-Approved Substances) and TB-500 under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics)
, Ente Accreditato in Regione Veneto
The two goals are often sequenced rather than run at once, with a recovery focus while tissue settles and a growth focus afterward
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design